Vitamin D for your patients with chronic hepatitis C?

J Hepatol. 2013 Jan;58(1):184-9. doi: 10.1016/j.jhep.2012.07.026. Epub 2012 Aug 4.

Abstract

Vitamin D is increasingly becoming recognized as an important physiological regulator with pleiotropic functions outside of its classical role in skeletal homeostasis. A growing body of clinical evidence highlights the prevalence and risks of vitamin D deficiency in patients suffering from chronic hepatitis C infection, and vitamin D supplementation has been proposed as an adjunct to current standards of care. This review considers the experimental evidence for the anti-inflammatory, antifibrotic and antiviral effects of vitamin D, and discusses the therapeutic potential of vitamin D supplementation to protect against liver disease progression and improve responses to treatment.

Publication types

  • Review

MeSH terms

  • Bone Density Conservation Agents / therapeutic use*
  • Bone Diseases / drug therapy*
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Vitamin D / therapeutic use*
  • Vitamin D Deficiency / drug therapy*

Substances

  • Bone Density Conservation Agents
  • Vitamin D